TW209244B - - Google Patents

Download PDF

Info

Publication number
TW209244B
TW209244B TW080106871A TW80106871A TW209244B TW 209244 B TW209244 B TW 209244B TW 080106871 A TW080106871 A TW 080106871A TW 80106871 A TW80106871 A TW 80106871A TW 209244 B TW209244 B TW 209244B
Authority
TW
Taiwan
Prior art keywords
hours
medium
bacteria
grams
cultivation
Prior art date
Application number
TW080106871A
Other languages
English (en)
Chinese (zh)
Original Assignee
Boryung Biopharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boryung Biopharma Co Ltd filed Critical Boryung Biopharma Co Ltd
Application granted granted Critical
Publication of TW209244B publication Critical patent/TW209244B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW080106871A 1990-09-05 1991-08-29 TW209244B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900014019A KR930001382B1 (ko) 1990-09-05 1990-09-05 경구용 장티프스 생균백신 및 그의 제조방법

Publications (1)

Publication Number Publication Date
TW209244B true TW209244B (fr) 1993-07-11

Family

ID=19303271

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080106871A TW209244B (fr) 1990-09-05 1991-08-29

Country Status (8)

Country Link
JP (1) JPH0771471B2 (fr)
KR (1) KR930001382B1 (fr)
CN (1) CN1056876C (fr)
CH (1) CH683187A5 (fr)
ES (1) ES2037599B1 (fr)
GB (1) GB2248241B (fr)
IL (1) IL99138A (fr)
TW (1) TW209244B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727128B1 (fr) * 1994-11-17 1997-01-17 Fdm Pharma Moyens pour le traitement de prelevements susceptibles de renfermer des microorganismes pathogenes
GB0900350D0 (en) * 2009-01-09 2009-02-11 Cambridge Entpr Ltd Formulations of viable bacteria for oral delivery
JP6251179B2 (ja) * 2011-12-22 2017-12-20 バクシム アクチェンゲゼルシャフト 弱毒化サルモネラ株を高収量で生産する方法
WO2014005683A1 (fr) 2012-07-05 2014-01-09 Vaximm Ag Vaccin à adn, destiné à être utilisé chez des patients atteints de cancer du pancréas
GB2564481B (en) * 2017-07-14 2019-10-23 4D Pharma Leon S L U Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) * 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
JPS5522448A (en) * 1978-08-03 1980-02-18 Shin Meiwa Ind Co Ltd Rotary working table
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease
US4879239A (en) * 1983-11-03 1989-11-07 American Type Culture Collection Method of culturing freeze-dried microorganisms and resultant preparation

Also Published As

Publication number Publication date
IL99138A (en) 1995-10-31
GB2248241B (en) 1995-01-04
ES2037599B1 (es) 1994-02-01
CN1056876C (zh) 2000-09-27
KR920006496A (ko) 1992-04-27
KR930001382B1 (ko) 1993-02-27
CH683187A5 (fr) 1994-01-31
JPH05336950A (ja) 1993-12-21
CN1060110A (zh) 1992-04-08
ES2037599A1 (es) 1993-06-16
GB9117918D0 (en) 1991-10-09
JPH0771471B2 (ja) 1995-08-02
GB2248241A (en) 1992-04-01
IL99138A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
Bracco et al. Transformation reactions between pneumococcus and three strains of streptococci
WO1998054296A1 (fr) Milieu de culture renfermant de la levure ou de l'extrait de soja comme sources d'acides amines mais exempt de complexes proteiniques d'origine animale
US3856935A (en) Oral typhoid vaccine and method of preparing the same
US8557537B2 (en) Method for the production of overproducing Staphylococcus aureus strains
KR101951893B1 (ko) 전통발효식품 유래의 프로바이오틱스활성 락토바실러스 파라카제이 srcm102343 균주의 고농도 제조 방법
Sakai et al. Mortality of bifidobacteria in boiled yogurt
CN111925943B (zh) 天津拟甲小球藻及其培养方法与应用
Schmitt-Slomska et al. Group A Streptococcal L Forms I. Persistence Among Inoculated Mice
EP0112020B1 (fr) Microorganisme appartenant au streptococcus thermophilus et composition contenant ce microorganisme
KR930001382B1 (ko) 경구용 장티프스 생균백신 및 그의 제조방법
US9284526B2 (en) Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
Avadhani et al. Genetic transformation in Escherichia coli
SU492094A3 (ru) Способ получени живой брюшнотифозной вакцины
JP2637470B2 (ja) きのこの人工栽培方法
JPS61265085A (ja) 生菌保存安定性の良好なビフイズス菌培養物粉末の製造法
Kim High-viability lyophilized Bacille Calmette-Guerin vaccine produced by deep-culture technique
US4562070A (en) Method of enhancement of piliated phase of Bordetella bronchiseptica
Thigiel et al. Selection of strains and extraction procedures for optimum production of galactosidase from Kluyveromyces strains
RU2295563C1 (ru) Штамм бактерий lactococcus lactis subspecies lactis вкпм в-8558, используемый в производстве молочных продуктов, и способ получения стартерной культуры штамма lactococcus lactis subspecies lactis вкпм в-8558
Huntington On the behavior of Hemophilus influenzae in certain diseases of children
WO2009051511A1 (fr) Procédé de fabrication d'un concentré sec ou liquide ou de ferment de bifidobactéries
JPS58224685A (ja) ビフィドバクテリウム・ロンガムに属する新規微生物、その菌体の製造法および該微生物を含む組成物
US4038142A (en) Isolation and characterization of phenotypes of mycobacteria
CN117838740A (zh) 江西青霉菌和发酵茶在制备降血脂和/或降低肝损伤的药物中的应用
JPH0856650A (ja) 新規乳酸菌